Concepedia

Neil Collinson

NC

34

Publications

5.3K

Citations

28

H-Index

1995

Active since

Affiliations

Roche (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Roche (Switzerland)

Massachusetts General Hospital

MSD (UK) Limited (United Kingdom)

Neil Collinson is an author at Roche (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1995–2023

34

Publications

34

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA<sub>A</sub>Receptor

Neil Collinson, Frederick M. Kuenzi, Wolfgang Jarolimek et al. · Journal of Neuroscience · 2002 · 618 citations · Full text

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

Ronald van Vollenhoven, Paul Emery, Clifton O. Bingham et al. · Annals of the Rheumatic Diseases · 2012 · 387 citations · Full text

α5GABA <sub>A</sub> Receptors Mediate the Amnestic But Not Sedative-Hypnotic Effects of the General Anesthetic Etomidate

Victor Cheng, Loren J. Martin, Erin Elliott et al. · Journal of Neuroscience · 2006 · 241 citations · Full text

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Gerard R. Dawson, Karen Maubach, Neil Collinson et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 240 citations

Rows per page

1–5 of 34